Search results
...INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with...
Morningstar· 6 days agoAttorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Biogen Inc ...
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a...
Morningstar· 5 days agoBiogen Inc. (Nasdaq: BIIB) announced the European Commission (EC) has granted marketing authorization under exceptional circumstances and maintained orphan designation for ...
European Commission grants marketing approval to Biogen's ALS drug
Reuters· 5 days ago, opens new tab said on Thursday that the European Commission has granted marketing authorization...
Sangamo Therapeutics Inc [SGMO] stock was sold by BIOGEN INC. at the price of US$3.0 million – Knox...
Knox Daily· 2 days agoIn a filing, Sangamo Therapeutics Inc revealed its 10% Owner BIOGEN INC. unloaded Company’s shares for reported $3.0 million on Sep 26 ’23. In the deal valued at $0.50 per ...
...: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Biogen Inc. Class Action - ...
Benzinga· 4 days agoRobbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Biogen Inc. BIIB securities between ...
European Commission approves Biogen’s QALSODY for ALS treatment
Pharmaceutical Technology via Yahoo Finance· 5 days agoThe European Commission (EC) has granted marketing authorisation for Biogen's QALSODY (tofersen) an...
Denali's (DNLI) Candidate Selected for FDA's START Pilot Program
Zacks via Yahoo Finance· 7 hours agoDenali's (DNLI) DNL126, an investigational enzyme replacement therapy, gets selected for the START...
Biogen Inc. (Nasdaq: BIIB) Investors Notice: Class action lawsuit filed on behalf of investors; the...
Morningstar· 6 days agoInvestors can contact the law firm at no cost to learn more about recovering their losses. LOS ANGELES, May 29, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Biogen
Biogen Inc London Stock Price Today | NASDAQ 0R1B Live Ticker - Investing.com
Investing.com· 2 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to...
Morningstar· 6 days agoThe Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Biogen Inc. (“Biogen” or “the Company ...